Financhill
Back

23andMe Holding 10K Form

Sell
21

ME
23andMe Holding

Last Price:
4.93
Seasonality Move:
-17.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ME News And Ratings

See the #1 stock for the next 7 days that we like better than ME

ME Financial Statistics

Sales & Book Value

Annual Sales: $219.64M
Cash Flow: $-44.57M
Price / Cash Flow: 0
Annual Sales: $5.67
Price / Book: 0.95

Profitability

EPS (TTM): -26.20000
Net Income (TTM): $-631.48M
Gross Margin: $99.38M
Return on Equity: -157.09%
Return on Assets: -103.73%

23andMe Holding Earnings Forecast

Key 23andMe Holding Financial Ratios

  • The Gross Profit Margin over the past 5 years for ME is 45.25%.
  • The Selling, General & Administrative Expenses for ME have been equal to 93.67% of Gross Profit Margin.
  • The Research & Development expenses have been 93.50% of Revenue.
  • The Net Earning history of ME is -303.55% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 0 years.

23andMe Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ME
Website: 23andme.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.52
Quick Ratio: 1.29

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ME Technical Analysis vs Fundamental Analysis

Sell
21
23andMe Holding (ME) is a Sell

Is 23andMe Holding a Buy or a Sell?

  • 23andMe Holding stock is rated a Sell
    The current 23andMe Holding [ME] share price is $5.34. The Score for ME is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.